Immunization financing
In the year 2010, immunization spending in developing countries increased from US$6 to $15 per infant, on average, and these prices continue to rise. Furthermore, in these countries, many people live on less than $2 per day. This extreme poverty makes paying for vaccines nearly impossible despite their proven cost-effectiveness. As a result, immunization financing is a critical tool for providing access to lifesaving vaccines to those who need them most.
View resources on immunization financing
Key resources
Is the Pneumococcal Vaccine Advance Market Commitment Motivating Innovation and Increasing Manufacturing Capacity? Some Preliminary Answers (2012)
An article that provides preliminary evidence on the potential outcome of the pneumococcal vaccine Advance Market Commitment, an innovative immunization financing mechanism.
Reduced Price on Rotavirus Vaccines: Enough to Facilitate Access Where Most Needed? (2012)
An article that examines whether the reduced prices for rotavirus vaccine are affordable enough to facilitate access to the vaccine where it is most needed.
Featured PATH resources
Investing in Vaccines for the Developing World (2012)
A fact sheet that details the cost of developing and distributing vaccines in the developing world.
Advanced Immunization Management e-Learning Module: Immunization Financing (2009)
An e-learning tool designed to teach senior immunization managers why financial planning is important for their immunization program and how to develop an effective plan.
Page last updated: November 2012.
